Salvatore Novello

690 total citations
18 papers, 447 citations indexed

About

Salvatore Novello is a scholar working on Neurology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Salvatore Novello has authored 18 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 9 papers in Cellular and Molecular Neuroscience and 4 papers in Neurology. Recurrent topics in Salvatore Novello's work include Parkinson's Disease Mechanisms and Treatments (12 papers), Neurological disorders and treatments (8 papers) and Neurological diseases and metabolism (4 papers). Salvatore Novello is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (12 papers), Neurological disorders and treatments (8 papers) and Neurological diseases and metabolism (4 papers). Salvatore Novello collaborates with scholars based in Italy, Switzerland and France. Salvatore Novello's co-authors include Michele Morari, Alberto Brugnoli, Ludovico Arcuri, Derya R. Shimshek, Daniela Mercatelli, Carla Caccia, Elsa Melloni, Gloria Padoani, Erwan Bézard and Sandra Doveró and has published in prestigious journals such as Analytical Chemistry, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

Salvatore Novello

18 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Salvatore Novello Italy 12 299 157 107 98 87 18 447
Daniel Hernández-Baltazar Mexico 8 163 0.5× 196 1.2× 116 1.1× 45 0.5× 79 0.9× 19 406
Alberto Brugnoli Italy 10 241 0.8× 178 1.1× 87 0.8× 57 0.6× 44 0.5× 18 351
Chunchen Xiang China 9 150 0.5× 98 0.6× 137 1.3× 64 0.7× 50 0.6× 10 408
Jinchi Liao China 12 154 0.5× 111 0.7× 115 1.1× 99 1.0× 70 0.8× 19 400
Laura Montero United States 7 192 0.6× 227 1.4× 148 1.4× 80 0.8× 78 0.9× 7 491
Amjad Abuirmeileh Jordan 9 166 0.6× 150 1.0× 86 0.8× 70 0.7× 48 0.6× 24 437
Chrysoula Marogianni Greece 9 200 0.7× 98 0.6× 137 1.3× 64 0.7× 134 1.5× 18 452
Aanishaa Jhaldiyal United States 6 143 0.5× 100 0.6× 191 1.8× 122 1.2× 140 1.6× 6 437
Gary Rafaloff United States 6 202 0.7× 112 0.7× 82 0.8× 54 0.6× 37 0.4× 10 320
Lauriane Ramet Canada 6 192 0.6× 134 0.9× 212 2.0× 119 1.2× 102 1.2× 7 487

Countries citing papers authored by Salvatore Novello

Since Specialization
Citations

This map shows the geographic impact of Salvatore Novello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salvatore Novello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salvatore Novello more than expected).

Fields of papers citing papers by Salvatore Novello

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salvatore Novello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salvatore Novello. The network helps show where Salvatore Novello may publish in the future.

Co-authorship network of co-authors of Salvatore Novello

This figure shows the co-authorship network connecting the top 25 collaborators of Salvatore Novello. A scholar is included among the top collaborators of Salvatore Novello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salvatore Novello. Salvatore Novello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Lashuel, Hilal A., Anne‐Laure Mahul‐Mellier, Salvatore Novello, et al.. (2022). Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity. npj Parkinson s Disease. 8(1). 136–136. 33 indexed citations
2.
Mercatelli, Daniela, et al.. (2022). Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out Mice. Biomedicines. 10(4). 881–881. 7 indexed citations
3.
Novello, Salvatore, Daniel Ortiz, Laure Menin, et al.. (2022). On-Demand Nanoliter Sampling Probe for the Collection of Brain Fluid. Analytical Chemistry. 94(29). 10415–10426. 2 indexed citations
4.
Sarti, Alba Clara, Valentina Vultaggio-Poma, Simonetta Falzoni, et al.. (2021). Mitochondrial P2X7 Receptor Localization Modulates Energy Metabolism Enhancing Physical Performance. Function. 2(2). zqab005–zqab005. 43 indexed citations
5.
Regoni, Maria, Stefano Comai, Daniela Mercatelli, et al.. (2021). Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X Mouse. Biomedicines. 9(5). 514–514. 4 indexed citations
6.
Lashuel, Hilal A. & Salvatore Novello. (2021). Lewy body-associated proteins: victims, instigators, or innocent bystanders? The case of AIMP2 and alpha-synuclein. Neurobiology of Disease. 156. 105417–105417. 8 indexed citations
7.
Novello, Salvatore, Daniela Mercatelli, Alberto Brugnoli, et al.. (2021). In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity. Neurobiology of Disease. 162. 105579–105579. 10 indexed citations
8.
Regoni, Maria, Stefano Cattaneo, Daniela Mercatelli, et al.. (2020). Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicity. Cell Death and Disease. 11(11). 963–963. 16 indexed citations
9.
Brugnoli, Alberto, Salvatore Novello, Carla Caccia, et al.. (2020). Safinamide inhibits in vivo glutamate release in a rat model of Parkinson's disease. Neuropharmacology. 167. 108006–108006. 26 indexed citations
10.
Novello, Salvatore, et al.. (2019). Autophagy and LRRK2 in the Aging Brain. Frontiers in Neuroscience. 13. 1352–1352. 41 indexed citations
11.
Novello, Salvatore, Ludovico Arcuri, Sandra Doveró, et al.. (2018). G2019S LRRK2 mutation facilitates α-synuclein neuropathology in aged mice. Neurobiology of Disease. 120. 21–33. 53 indexed citations
12.
Gardoni, Fabrizio, Michele Morari, Jaime Kulisevsky, et al.. (2018). Safinamide Modulates Striatal Glutamatergic Signaling in a Rat Model of Levodopa-Induced Dyskinesia. Journal of Pharmacology and Experimental Therapeutics. 367(3). 442–451. 27 indexed citations
13.
Casali, Massimiliano, et al.. (2018). Alleged malpractice in orthopaedics. Analysis of a series of medmal insurance claims. Journal of Orthopaedics and Traumatology. 19(1). 7–7. 18 indexed citations
14.
Mercatelli, Daniela, et al.. (2018). NOP Receptor Ligands and Parkinson’s Disease. Handbook of experimental pharmacology. 254. 213–232. 11 indexed citations
15.
Tozzi, Alessandro, Valentina Durante, Petra Mazzocchetti, et al.. (2018). Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease. Neurobiology of Disease. 118. 1–8. 23 indexed citations
16.
Morari, Michele, Alberto Brugnoli, Salvatore Novello, et al.. (2017). Safinamide Differentially Modulates In Vivo Glutamate and GABA Release in the Rat Hippocampus and Basal Ganglia. Journal of Pharmacology and Experimental Therapeutics. 364(2). 198–206. 41 indexed citations
17.
Longo, Francesco, Daniela Mercatelli, Salvatore Novello, et al.. (2017). Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice. Acta Neuropathologica Communications. 5(1). 22–22. 69 indexed citations
18.
Arcuri, Ludovico, Salvatore Novello, Daniela Mercatelli, et al.. (2017). Anti‐Parkinsonian and anti‐dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists. British Journal of Pharmacology. 175(5). 782–796. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Hernández-Baltazar Breakdown of academic impact, for papers by Alberto Brugnoli Breakdown of academic impact, for papers by Chunchen Xiang Breakdown of academic impact, for papers by Jinchi Liao Breakdown of academic impact, for papers by Laura Montero Breakdown of academic impact, for papers by Amjad Abuirmeileh Breakdown of academic impact, for papers by Chrysoula Marogianni Breakdown of academic impact, for papers by Aanishaa Jhaldiyal Breakdown of academic impact, for papers by Gary Rafaloff Breakdown of academic impact, for papers by Lauriane Ramet
Rankless by CCL
2026